Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2023-04-11

EMA Authorised: Granpidam (sildenafil citrate) — Accord Healthcare S.L.U.

View source ↗

Summary

Granpidam (sildenafil citrate) has been authorised in the EU for use in hypertension and pulmonary hypertension with Accord Healthcare S.L.U. as the marketing a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Granpidam (sildenafil citrate)

Snippet

Status: Authorised. Therapeutic area: Hypertension, Pulmonary. MAH: Accord Healthcare S.L.U.. Decision date: 30/03/2023